616 related articles for article (PubMed ID: 15377292)
21. Hereditary hemochromatosis: the clinical significance of the S65C mutation.
Asberg A; Thorstensen K; Hveem K; Bjerve KS
Genet Test; 2002; 6(1):59-62. PubMed ID: 12180078
[TBL] [Abstract][Full Text] [Related]
22. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis.
Gurrin LC; Osborne NJ; Constantine CC; McLaren CE; English DR; Gertig DM; Delatycki MB; Southey MC; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ;
Gastroenterology; 2008 Dec; 135(6):1945-52. PubMed ID: 18848943
[TBL] [Abstract][Full Text] [Related]
23. Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.
Aranda N; Viteri FE; Montserrat C; Arija V
Ann Hematol; 2010 Aug; 89(8):767-73. PubMed ID: 20107990
[TBL] [Abstract][Full Text] [Related]
24. Hereditary hemochromatosis in north-eastern Romania.
Voicu PM; Cojocariu C; Petrescu-Dănilă E; Stanciu C; Covic M; Rusu M; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):982-7. PubMed ID: 21495455
[TBL] [Abstract][Full Text] [Related]
25. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
Pedersen P; Milman N
Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
[TBL] [Abstract][Full Text] [Related]
26. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
27. Screening for iron overload in the Turkish population.
Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
[TBL] [Abstract][Full Text] [Related]
28. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
[TBL] [Abstract][Full Text] [Related]
29. Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population.
Rossi E; Bulsara MK; Olynyk JK; Cullen DJ; Summerville L; Powell LW
Clin Chem; 2001 Feb; 47(2):202-8. PubMed ID: 11159767
[TBL] [Abstract][Full Text] [Related]
30. Effect of C282Y genotype on self-reported musculoskeletal complications in hereditary hemochromatosis.
Camacho A; Funck-Brentano T; Simão M; Cancela L; Ottaviani S; Cohen-Solal M; Richette P
PLoS One; 2015; 10(3):e0122817. PubMed ID: 25822977
[TBL] [Abstract][Full Text] [Related]
31. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women.
Warne CD; Zaloumis SG; Bertalli NA; Delatycki MB; Nicoll AJ; McLaren CE; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ; Gurrin LC;
J Gastroenterol Hepatol; 2017 Apr; 32(4):797-802. PubMed ID: 27784128
[TBL] [Abstract][Full Text] [Related]
32. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
[TBL] [Abstract][Full Text] [Related]
33. A primer for predicting risk of disease in HFE-linked hemochromatosis.
Adams PC; Walker AP; Acton RT
Genet Test; 2001; 5(4):311-6. PubMed ID: 11960576
[TBL] [Abstract][Full Text] [Related]
34. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.
McLaren CE; Barton JC; Gordeuk VR; Wu L; Adams PC; Reboussin DM; Speechley M; Chang H; Acton RT; Harris EL; Ruggiero AM; Castro O;
Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476
[TBL] [Abstract][Full Text] [Related]
35. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
36. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
[TBL] [Abstract][Full Text] [Related]
37. Haematological effects of the C282Y HFE mutation in homozygous and heterozygous states among subjects of northern and southern European ancestry.
Beutler E; Felitti V; Gelbart T; Waalen J
Br J Haematol; 2003 Mar; 120(5):887-93. PubMed ID: 12614226
[TBL] [Abstract][Full Text] [Related]
38. Hemochromatosis mutations in the general population: iron overload progression rate.
Andersen RV; Tybjaerg-Hansen A; Appleyard M; Birgens H; Nordestgaard BG
Blood; 2004 Apr; 103(8):2914-9. PubMed ID: 15070663
[TBL] [Abstract][Full Text] [Related]
39. [Prevalence of hemochromatosis-associated mutations in the hemochromatosis gene in the Danish population].
Larsen LE; Ellervik C; Appleyard M; Nordestgaard BG; Birgens H; Tybjaerg-Hansen A
Ugeskr Laeger; 2002 Sep; 164(39):4545-7. PubMed ID: 12380399
[TBL] [Abstract][Full Text] [Related]
40. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.
Pelucchi S; Mariani R; Calza S; Fracanzani AL; Modignani GL; Bertola F; Busti F; Trombini P; Fraquelli M; Forni GL; Girelli D; Fargion S; Specchia C; Piperno A
Haematologica; 2012 Dec; 97(12):1818-25. PubMed ID: 22773607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
